Delhi-based Contract Research Organization (CRO) Auriga Research Private Limited has entered into a strategic agreement with San Francisco Research Institute (SFRI), a US-based healthcare research and innovation organization, to advance global clinical research and AI-driven support for the healthcare industry. The collaboration aims to strengthen global clinical research, promote AI-integrated healthcare solutions, and expand access to compliant wellness products across India, the United States, and Africa.
Strategic Partnership Framework
The partnership outlines a joint framework to support clinical trials, regulatory pathways, digital health innovation, and international business development. It brings together Auriga's strong infrastructure and expertise in India and Asia with SFRI's global capabilities across North America, Europe, and Africa.
"This strategic partnership with SFRI reflects our commitment to advancing global standards in clinical research and healthcare innovation. By leveraging our strengths in regulatory science, AI-driven trials, and product development, we aim to expand access to safe, effective, and globally compliant health solutions across India, the US, and Africa," said Saurabh Arora, Managing Director of Auriga Research.
Key Collaboration Areas
The partnership encompasses several key areas of cooperation:
Clinical Research Operations: Joint clinical trials will utilize AI for patient recruitment, monitoring, and analytics. Auriga will lead clinical operations, data management, and regulatory execution in India, while SFRI will drive client engagement and market expansion in the US, Japan, and Europe.
Product Development: The organizations will co-develop new formulations and wellness products for global markets, focusing on evidence-based wellness solutions that comply with international regulatory standards.
Regulatory Support: SFRI will support regulatory strategy, public health collaboration, and commercial partnerships in markets such as Nigeria and the US. This includes enabling product registration with national health agencies, connecting Auriga to distributors and marketers, and directly supporting sales outreach and supply chain strategies.
AI Integration and Training Programs
"This partnership combines Auriga's clinical research expertise with our strengths in AI and regulatory capabilities to accelerate the development of compliant, patient-centric health innovations. It marks a strategic step toward bridging global regulatory ecosystems and scaling evidence-based wellness solutions across geographies by managing regulatory submissions and ensuring compliance with agencies such as the FDA, EFSA, TGA, and others," said John Ademola, CEO of SFRI.
The two organizations will jointly expand their Research Training Program through both digital platforms and in-person sessions, while also co-developing new products and AI applications for healthcare. Additionally, both organizations will pursue government and foundation-funded projects to further their impact on global health systems.
Market Expansion Strategy
The collaboration will help identify untapped opportunities in North America, Europe, Asia-Pacific, and other emerging markets. SFRI will connect Auriga with marketers and public health agencies in Africa for expansion, particularly focusing on the Nigerian market alongside US operations.
Joint applications for grants and funded clinical research projects will be pursued to support the partnership's objectives of advancing global health systems and expanding access to compliant wellness products across multiple continents.
